Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Efficacy on Esophageal Function and Remodeling in Adult Participants With Eosinophilic Esophagitis (EoE)
NCT06101095Phase 4Active, not recruiting
- Sponsor
- Sanofi
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 4 trial of dupilumab in eosinophilic esophagitis (EoE), sponsored by Sanofi. Started Nov 2023; status: active, not recruiting.
02
Drugs
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT06101095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101095.